Overall rank by patents
#28,080
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Aegea Biotechnologies
USPTO PatentsView assignee record - 9 granted patents across 3 technology areas, active 2017–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
9
Total patents granted
3
CPC technology areas
7.8
Avg claims per patent
-71%
5-year filing velocity
The verdict
Aegea holds 9 US patents across 3 technology areas, rank #28,080 of 50,000 tracked assignees.
- #28,080
- of 50,000 US assignees by volume
- Top 95%
- by Innovation Score (18.7/100)
- 7.8
- avg claims per patent
- -71%
- filing velocity, last 5 yrs
Portfolio overview
Aegea Biotechnologies has been granted 9 US utility patents between 2017 and 2020, placing Aegea Biotechnologies at rank #28,080 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.8 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, Aegea Biotechnologies is one of the more focused assignees in the PatentsView dataset. By volume, Aegea sits between Advanced Innergy Ltd (9 patents, rank #28,076) and Agricultural Research Council (9 patents, rank #28,084) - the closest US assignees by grant volume. The composite Innovation Score of 18.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 7 in the 2015–2019 window, a -71% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Aegea Biotechnologies's 7.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Aegea Biotechnologies against peers pursuing similar technology classes.
Who files at Aegea's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Advanced Innergy
Advanced Innergy Ltd
9 patents
- Advanced Mechanic…
Advanced Mechanical Technology, Inc.
9 patents
- Advanced Protein
Advanced Protein Technologies Corp.
9 patents
- Adventure Wagon
Adventure Wagon LLC
9 patents
- Aerkodo
AerKodo, LLC
9 patents
- Aeromotive
Aeromotive, LLC
9 patents
- Affordable Wire M…
Affordable Wire Management, LLC
9 patents
- Agricultural Rese…
Agricultural Research Council
9 patents
- Aegea Biotechnolo… ◀
Aegea Biotechnologies
9 patents
What this shows Aegea holds 9 patents at rank #28,080, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Aegea
By rank, the assignees closest to #28,080 in granted patent volume.
- Advanced Innergy Ltd #28,076 · 9 patents
- Advanced Mechanical Technology, Inc. #28,077 · 9 patents
- Advanced Protein Technologies Corp. #28,078 · 9 patents
- Adventure Wagon Llc #28,079 · 9 patents
- Aerkodo, Llc #28,081 · 9 patents
- Aeromotive, Llc #28,082 · 9 patents
- Affordable Wire Management, Llc #28,083 · 9 patents
- Agricultural Research Council #28,084 · 9 patents
Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)
Other assignees with the most granted patents in Aegea's primary technology class.
- The Regents Of The University Of California 581 in class
- Life Technologies Corporation 546 in class
- Illumina, Inc. 445 in class
- President And Fellows Of Harvard College 387 in class
- Immatics Biotechnologies Gmbh 286 in class
- 10x Genomics, Inc. 282 in class
- The Board Of Trustees Of The Leland Stanford Junior University 266 in class
- Pacific Biosciences OF California, Inc. 259 in class
Aegea's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
19 Top 95% higher than 5% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 11.1% |
| 2018 | 3 | 33.3% |
| 2019 | 3 | 33.3% |
| 2020 | 2 | 22.2% |
Which technologies does Aegea Biotechnologies patent most?
Top 3 of 3 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple
Velocity Declining
Frequently Asked Questions
How many patents does Aegea Biotechnologies hold?
Aegea Biotechnologies holds 9 US granted patents filed between 2017 and 2020, spanning 3 technology areas.
What is Aegea Biotechnologies's Innovation Score?
Aegea Biotechnologies has an Innovation Score of 18.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Aegea Biotechnologies focus on?
Aegea Biotechnologies's top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 9 patents. The company has filed patents in 3 CPC subclasses total.
Is Aegea Biotechnologies's patent filing rate increasing or decreasing?
Aegea Biotechnologies's recent filing velocity is -71% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Aegea Biotechnologies's patents?
Aegea Biotechnologies's patents average 7.8 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Aegea Biotechnologies patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Aegea's 9 grants land it in the top 95% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Aegea ranks #28,080 of 50,000. Top 50 holders
- Most of this portfolio concentrates in C12Q - see who else leads that technology area. C12Q leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.